Total Payments
$25,449
2024 Payments
$2,968
Companies
61
Transactions
1,261
Medicare Patients
2,610
Medicare Billing
$238,644
Payment Breakdown by Category
Food & Beverage$25,184 (99.0%)
Education$265.14 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,184 | 1,241 | 99.0% |
| Education | $265.14 | 20 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,272 | 150 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,853 | 112 | $0 (2024) |
| ABBVIE INC. | $2,796 | 170 | $0 (2024) |
| Novo Nordisk Inc | $1,882 | 75 | $0 (2024) |
| Gilead Sciences, Inc. | $1,491 | 67 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,287 | 66 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,071 | 68 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $900.41 | 46 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $865.58 | 37 | $0 (2021) |
| PFIZER INC. | $806.10 | 48 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,968 | 138 | ABBVIE INC. ($421.85) |
| 2023 | $2,837 | 145 | AbbVie Inc. ($585.86) |
| 2022 | $3,012 | 158 | ABBVIE INC. ($612.53) |
| 2021 | $3,722 | 196 | AbbVie Inc. ($837.23) |
| 2020 | $2,979 | 149 | Boehringer Ingelheim Pharmaceuticals, Inc. ($371.42) |
| 2019 | $3,266 | 162 | Boehringer Ingelheim Pharmaceuticals, Inc. ($594.62) |
| 2018 | $2,779 | 139 | Boehringer Ingelheim Pharmaceuticals, Inc. ($586.70) |
| 2017 | $3,886 | 174 | Boehringer Ingelheim Pharmaceuticals, Inc. ($596.12) |
All Payment Transactions
1,261 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: UROLOGY | ||||||
| 12/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.23 | General |
| Category: GI | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.76 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Obesity | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Diabetes | ||||||
| 11/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $33.39 | General |
| Category: Biological | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $33.38 | General |
| Category: Biological | ||||||
| 11/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 617 | 937 | $121,837 | $60,267 |
| 2022 | 10 | 653 | 1,000 | $126,474 | $62,595 |
| 2021 | 11 | 685 | 969 | $126,114 | $65,672 |
| 2020 | 10 | 655 | 926 | $117,600 | $50,109 |
Total Patients
2,610
Total Services
3,832
Medicare Billing
$238,644
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 223 | $47,040 | $23,483 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 174 | $24,485 | $13,655 | 55.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 73 | 120 | $25,313 | $12,556 | 49.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 44 | 64 | $9,006 | $5,042 | 56.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 102 | 153 | $2,295 | $1,285 | 56.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 78 | 88 | $4,977 | $1,079 | 21.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $980.00 | $960.40 | 98.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 27 | 27 | $3,949 | $895.25 | 22.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 29 | 32 | $2,728 | $698.88 | 25.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 28 | 28 | $1,064 | $613.20 | 57.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 207 | $43,665 | $21,974 | 50.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 75 | 163 | $34,383 | $18,162 | 52.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 98 | 178 | $25,048 | $14,151 | 56.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 31 | 37 | $5,207 | $2,974 | 57.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 91 | 104 | $5,882 | $1,230 | 20.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 32 | 34 | $1,190 | $1,168 | 98.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 29 | 30 | $4,388 | $990.83 | 22.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 36 | 36 | $1,368 | $759.24 | 55.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 31 | 31 | $2,643 | $654.67 | 24.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 112 | 180 | $2,700 | $532.83 | 19.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 125 | 205 | $43,137 | $22,316 | 51.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 117 | 211 | $29,622 | $17,366 | 58.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 79 | 122 | $25,735 | $14,294 | 55.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 37 | 45 | $6,332 | $3,868 | 61.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $4,850 | $2,254 | 46.5% |
About Dr. Michael Correa, MD
Dr. Michael Correa, MD is a Internal Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083765531.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Correa, MD has received a total of $25,449 in payments from pharmaceutical and medical device companies, with $2,968 received in 2024. These payments were reported across 1,261 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($25,184).
As a Medicare-enrolled provider, Correa has provided services to 2,610 Medicare beneficiaries, totaling 3,832 services with total Medicare billing of $238,644. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location New York, NY
- Active Since 01/12/2007
- Last Updated 04/25/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083765531
Products in Payments
- FARXIGA (Drug) $1,611
- JARDIANCE (Drug) $1,381
- VRAYLAR (Drug) $1,373
- XIFAXAN (Drug) $973.74
- Ozempic (Drug) $801.82
- SPIRIVA RESPIMAT (Drug) $796.54
- UBRELVY (Drug) $783.67
- ENTRESTO (Drug) $694.79
- TRELEGY ELLIPTA (Drug) $667.78
- SYMBICORT (Drug) $648.96
- Vascepa (Drug) $641.01
- TOUJEO (Drug) $538.54
- BREZTRI (Drug) $534.40
- AFREZZA (Drug) $478.96
- QULIPTA (Drug) $464.76
- STIOLTO RESPIMAT (Drug) $456.06
- Kerendia (Drug) $446.97
- TRULICITY (Drug) $397.05
- ELIQUIS (Drug) $355.31
- Veozah (Drug) $333.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New York
Dr. Stephen Saletan, M.d, M.D
Internal Medicine — Payments: $2.7M
Internal Medicine $2.7M
Michael Schuster, Md, MD
Internal Medicine — Payments: $2.1M
Internal Medicine $2.1M
Dr. Ziad Ali, Md Dphil, MD DPHIL
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Dr. James Underberg, Md, MD
Internal Medicine — Payments: $1.5M
Internal Medicine $1.5M
Dr. Ricky Hsu, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Gail Roboz, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M